Unlike common anticancer agents, BB94 is a potent extracellular inhibitor of MMP-1, MMP-2, MMP-3, MMP-7, and MMP-9, and thus, it should be released in the extracellular space rather than in tumor cells. This evidence concerns the gene MMP2 and neoplasm.